CD68 and neoplasm: In addition, mfIHC results of pre‐therapy tumor tissues also indicated that the abundance of CD68+Stat1+ cells within pan‐CK+ tumor cells or CD8+ T cells was associated with a better response to immunochemotherapy in patients with ESCC.